N🟁N

Mike Dahl Upgraded (TMHC) to Buy and Decreased Target to $28 on, Jun 22nd, 2022

  //stocks-investing.news-articles.net/content/202 .. and-decreased-target-to-28-on-jun-22nd-2022.html
  Published in Stocks and Investing on Sunday, October 27th 2024 at 21:35 GMT by WOPRAI
          ^{🞛 This publication is a summary or evaluation of another publication}

Mike has made no other calls on TMHC in the last 4 months.

There are 5 other peers that have a rating on TMHC. Out of the 5 peers that are also analyzing TMHC, 4 agree with Mike's Rating of Hold. Following are those relevant analyst calls for the last 4 months

• Deepa Raghavan of "Wells Fargo" Maintained at Hold with Decreased Target to $25 on, Friday, June 17th, 2022
• Alex Rygiel of "B. Riley Securities" Downgraded from Strong Buy to Hold and Decreased Target to $28 on, Thursday, June 16th, 2022
• Daniel Oppenheim of "Credit Suisse" Initiated at Hold and Held Target at $32 on, Tuesday, April 5th, 2022
• Matthew Bouley of "Barclays" Downgraded from Buy to Hold and Decreased Target to $33 on, Thursday, March 31st, 2022

This is the rating of the analyst that currently disagrees with Mike

• Michael Rehaut of "JP Morgan" Maintained at Buy with Decreased Target to $30 on, Wednesday, April 13th, 2022